Analysts had predicted that a successful launch of evobrutinib was key to Mercks goal of generating 25 billion (US$ 27 billion) in sales by 2025, up from US$ 22.2 billion in 2022
Stem Cells 30:11441151 Suzuki M, McHugh J, Tork C et al (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS
FDA-approved GLP-1 receptor agonists represent a distinct class of prescription medications with well-established efficacy and safety profiles
BPC-157 is a synthetic 15-amino-acid peptide derived from a naturally occurring gastric-juice protein, prized in laboratory models for its potent tissue repair and angiogenic signaling
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Yu E.A., He S., Jones D.P., Sun Y.V., Ramirez-Zea M., Stein A.D
E.AltmanR